Investment Fraud |

Stock Market Investment Fraud News

Cell Therapeutics Class Action Lawsuit Dismissed

RSS News Feeds
Investment Fraud
Stock Market Investment Fraud
Healthsouth
Internet Stocks / Dot Com
Worlcomm
Enron
 All RSS Feeds

At a glance:

A US District Court Judge has granted a motion to dismiss a class action lawsuit against cancer drug maker Cell Therapeutics Inc. 
 
The lawsuit alleged false statements by the company concerning trials of lung cancer drug Xyotax. Investors who bought Cell Therapeutics stock between November 2003 and March 2005 claim the company made money on stock offerings under false pretenses. 
 
The drug is still being tested.

US Court Dismisses Securities Action Lawsuit Against Cell ...

Trading Markets - 6/9/2006 9:27 AM

(RTTNews) - Friday, cancer drug maker Cell Therapeutics, Inc. said U.S. District Judge Ricardo Martinez has granted its motion to dismiss a private securities fraud class action lawsuit. The lawsuit F.L. titled Heywood, et al, was filed on November 7, 2005 and alleged of making false statements by company officers. The Judge's decision was issued May 4 but went into permanent effect on June 8, 2006.
 
· Read The Full Stock Market Investment Fraud Article From Trading Markets -->

· Read All Stock Market Investment Fraud News Stories -->

Comments On Stock Market Investment Fraud News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: